"Monongahela Valley Hospital (MVH) is a 200-bed, full-service health care facility with a 225-member medical staff representing more than 40 medical specialties."

During the past decade, Monongahela Valley Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Monongahela Valley Hospital" #1 sponsor was "Johns Hopkins University" with 2 trials, followed by "Calithera Biosciences, Inc" with 1 trials sponsored, "Helsinn Healthcare SA" with 1 trials sponsored, "MacroGenics" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monongahela Valley Hospital" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator, "Maryland Medical Research Institute" with 1 trials as a collaborator and "The Physicians' Services Incorporated Foundation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Monongahela Valley Hospital" are "Angina" (1 trials), "Angina Pectoris" (1 trials), "Chemotherapy-induced Nausea and Vomiting" (1 trials), "Clear Cell Renal Cell Carcinoma" (1 trials) and "Colonic Neoplasms" (1 trials). Many other conditions were trialed in "Monongahela Valley Hospital" in a lesser frequency.

Most popular intervention types in "Monongahela Valley Hospital" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CB-839" (1 trials), "Margetuximab" (1 trials), "Percutaneous coronary intervention (PCI)" (1 trials), "Physician's choice of chemotherapy." (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Monongahela Valley Hospital" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Monongahela Valley Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Monongahela Valley Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Monongahela Valley Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".